Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ADMA BIOLOGICS, INC. | Director | Common Stock | 83.9K | $442K | $5.26 | Feb 26, 2024 | Direct |
ADMA BIOLOGICS, INC. | Director | Stock Option (right to buy) | 37.5K | $137K | $3.66 | Feb 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADMA | ADMA BIOLOGICS, INC. | Feb 26, 2024 | 2 | $0 | 4 | Feb 28, 2024 | Director |
ADMA | ADMA BIOLOGICS, INC. | Aug 22, 2023 | 1 | -$5.54M | 4 | Aug 23, 2023 | Director |
ADMA | ADMA BIOLOGICS, INC. | Mar 6, 2023 | 2 | $0 | 4 | Mar 8, 2023 | Director |
ADMA | ADMA BIOLOGICS, INC. | Mar 7, 2022 | 2 | $0 | 4 | Mar 9, 2022 | Director |
DMAQ | Deep Medicine Acquisition Corp. | Oct 26, 2021 | 0 | $0 | 3 | Oct 26, 2021 | Director |